153 related articles for article (PubMed ID: 25785029)
1. Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.
Chen J; Liu X; Jiao H; Peng L; Huo Z; Yang W; Shen Q; Li T; Liu Q
Int J Clin Exp Med; 2015; 8(1):546-57. PubMed ID: 25785029
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis.
Ji K; Zhang L; Zhang M; Chu Q; Li X; Wang W
Medicine (Baltimore); 2016 Feb; 95(5):e2641. PubMed ID: 26844481
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of STAT3/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis.
He S; Liao G; Liu Y; Huang L; Kang M; Chen L
Int J Clin Exp Med; 2015; 8(11):20014-23. PubMed ID: 26884913
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.
Li T; Chen J; Liu QL; Huo ZH; Wang ZW
Eur Rev Med Pharmacol Sci; 2014; 18(18):2693-703. PubMed ID: 25317805
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.
Chen J; Li T; Wu Y; He L; Zhang L; Shi T; Yi Z; Liu M; Pang X
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1799-812. PubMed ID: 21918901
[TBL] [Abstract][Full Text] [Related]
6. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
[TBL] [Abstract][Full Text] [Related]
7. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
[TBL] [Abstract][Full Text] [Related]
10. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
[TBL] [Abstract][Full Text] [Related]
13. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ji K; Zhang M; Chu Q; Gan Y; Ren H; Zhang L; Wang L; Li X; Wang W
PLoS One; 2016; 11(8):e0160125. PubMed ID: 27504822
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-specific peptidase 22 inhibits colon cancer cell invasion by suppressing the signal transducer and activator of transcription 3/matrix metalloproteinase 9 pathway.
Ao N; Liu Y; Bian X; Feng H; Liu Y
Mol Med Rep; 2015 Aug; 12(2):2107-13. PubMed ID: 25902005
[TBL] [Abstract][Full Text] [Related]
16. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
17. Role of STAT3 Expression in Thyroid Cancer: A Meta-Analysis and Systematic Review Based on the Chinese Population.
Liang YN; Zhang Z; Song J; Yang F; Yang P
Evid Based Complement Alternat Med; 2022; 2022():1116535. PubMed ID: 35463085
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
20. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
